DBV Technologies S.A. (DBVT) Q2 2026 Earnings Call

DBV Technologies S.A. (DBVT) Q2 2026 Earnings Call July 16, 2026 5:00 PM EDTCompany ParticipantsJonathan Neely - VP & Head of Investor RelationsDaniel...

Company Participants Jonathan Neely - VP & Head of Investor Relations Daniel Tassé - CEO & Director Pharis Mohideen - Chief Medical Officer Kevin Trapp - Chief Commercial Officer Conference Call Participants Yatin Suneja - Guggenheim Securities, LLC, Research Division Sushila Hernandez Kristen Kluska - Cantor Fitzgerald & Co., Research Division Jonathan Wolleben - Citizens JMP Securities, LLC, Research Division Samuel Slutsky - LifeSci Capital, LLC, Research Division Presentation Operator Welcome to the DBV Second Quarter 2026 Results and Business Update Conference Call. [Operator Instructions] Please note, this event is being recorded.

I would now like to turn the conference over to Jonathan Neely, Investor Relations. Please go ahead, sir. Jonathan Neely VP & Head of Investor Relations Thank you.

Good afternoon. DBV Technologies reported financial results for the second quarter and half year of 2026. This update is available in the Press Releases section of the DBV Technologies website.

Before we begin, please note that today's call may include a number of forward-looking statements, including, but not limited to, comments regarding our forecast of estimated cash runway, clinical and regulatory development plans, the design and conduct of our clinical trials, the timing and the results of interactions with regulatory agencies and the ability of any of our product candidates, if approved, to improve the lives of patients with food allergies. These forward-looking statements are based on assumptions that are subject to risks and uncertainties that could cause the company's actual results to differ significantly from those suggested by these statements.

Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. Please refer to the company's filings with the SEC and the French AMF for information concerning risk factors that could cause the company's actual results to differ

Why this matters locally

This business story matters locally because it may affect readers, businesses, commuters, families, or public services in British Columbia.

Local impact

BC Post links this item to British Columbia coverage so readers can follow related city updates, weather, traffic, events, and category news in one place.

Timeline